One of Bristol-Myers’s largest shareholders is opposing the company’s $74 billion deal to buy rival Celgene, becoming the latest investor to express its unhappiness with the transaction.
from WSJ.com: US Business https://ift.tt/2Vp3T2t
Subscribe to:
Post Comments (Atom)
Why Jensen Huang says now is an 'incredible time' to be a software company
Nvidia CEO Jensen Huang said it's a great time to be a software company. Bloomberg/Getty Images Jensen Huang gave software companies a r...
-
Big Tech is emerging a winner in the new H-1B system, while early-stage startups could lose out. Matthias Balk/nirat/Getty/Getty Images ...
-
Student-loan borrowers said they're worried about higher payments without the SAVE plan. Aaron Hawkins/Getty Images/iStockphoto Tru...
-
Healthcare costs will change for Americans in 2026. Reza Estakhrian/Getty Images Health insurance costs are expected to rise for Americ...
No comments:
Post a Comment